Passage timing calculation device, passage timing calculation method, and recording medium for recording program
US-2024352397-A1 · Oct 24, 2024 · US
Induced pluripotent stem cell produced by transfecting a human neural stem cell with an episomal vector encoding the Oct4 and Nanog proteins
US9340775B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9340775-B2 |
| Application number | US-201013259668-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 24, 2010 |
| Priority date | Mar 25, 2009 |
| Publication date | May 17, 2016 |
| Grant date | May 17, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Methods and compositions for the generation and use of footprint-free human induced pluripotent stem cells are provided.
First claim
Opening claim text (preview).
What is claimed is: 1. A footprint-free human induced pluripotent stem cell comprising an episomal vector comprising a nucleic acid encoding an Oct4 protein, and an episomal vector comprising a nucleic acid encoding a Nanog protein, wherein the footprint-free human induced pluripotent stem cell does not contain any detectable genomic integration of the episomal vector nucleic acid encoding the Oct4 protein or the episomal nucleic acid encoding the Nanog protein. 2. A method for preparing a footprint-free human induced pluripotent stem cell comprising: (i) transfecting a human neural stem cell with a nucleic acid encoding an Oct4 protein to form a transfected human neural stem cell, wherein the nucleic acid encoding the Oct4 protein is comprised in an episomal vector comprising an Epstein-Barr associated nuclear antigen 1 (EBNA-1) gene and an OriP nucleic acid sequence, transfecting the human neural stem cell with a nucleic acid encoding a Nanog protein, wherein the nucleic acid encoding the Nanog protein is comprised in an episomal vector comprising an Epstein-Barr associated nuclear antigen 1 (EBNA-1) gene and an OriP nucleic acid sequence, wherein said transfecting is performed without the use of a viral transfection system; and (ii) culturing the transfected human neural stem cell under embryonic stem cell conditions thereby forming said footprint-free human induced pluripotent stem cell. 3. The method of claim 2 , wherein said nucleic acid encoding the Oct4 protein and said nucleic acid encoding the Nanog protein are comprised in the same episomal vector. 4. The method of claim 2 , wherein said nucleic acid encoding the Oct4 protein is comprised in a first episomal vector and said nucleic acid encoding the Nanog protein is comprised in a second episomal vector. 5. The method of claim 2 , wherein said human neural stem cell is not transfected with an additional nucleic acid encoding a Wye protein, a Sox2 protein, a Lin28 protein or a KLF4 protein. 6. The method of claim 2 , wherein said human neural stem cell is isolated from a human embryo. 7. The method of claim 2 , wherein said human neural stem cell is derived from a human embryonic stem cell.
Assignees
Inventors
Classifications
Oct-3/4 · CPC title
connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts" · CPC title
Neurons · CPC title
from cells of the nervous system · CPC title
Nucleic acids vectors · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9340775B2 cover?
- Methods and compositions for the generation and use of footprint-free human induced pluripotent stem cells are provided.
- Who is the assignee on this patent?
- Muotri Alysson R, Gage Fred H, Marchetto Maria C N, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification C12N5/0696. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).